We previously demonstrated maternal monoaltelic expression of the Wilms tumor suppressor gene, WT1, in about half of pre-term placental villus and fetal brain tissues examined. There were two alternative explanations for this pattern of the WT1 expression, i.e., an imprinting polymorphism vs. a developmental stage-dependent switching from monoatlelic to biallelic expression of the gene. To investigate these possibilities, we examined WT1 expression in a larger number of villus samples (46 samples) with gestational ages ranging from 4 to 21 weeks, using reverse transcriptase-based polymerase chain reaction (RT-PCR) to amplify the sequences for polymorphic sites in the 3'-untranslated region (UTR) of WT1. Maternal monoallelic expression was observed in 7 (39%) of 18 samples informative for the polymorphism, while the expression of the remaining 11 samples was biallelic. In addition, there was no correlation between expression patterns and gestational ages of the samples. The results indicate that the pattern of expression (monoallelic vs. biallelic) is polymorphic. The expression patterns were also studied in five different organs from a 21-week-old fetus, showing monoallelic expression only in the placenta and biallelic expression in other organs (heart, lung, liver and intestine). The finding supports the tissue specificity of the WT1 monoallelic expression°
INTRODUCTION
Genomic imprinting is a phenomenon in which maternal and paternal alleles are epigenetically modified before conception and the modified and unmodified parental alleles are differentially expressed in offspring. Nine imprinted genes have been identified in man: the insulin-like growth factor II gene (tGF2) (Ohlsson et a/., 1993; Giannoukakis et al., 1993) and its receptor gene (IGF2R) (Xu et al., 1993) , H19 gene (H19) (Zang and Tycko, 1992) , the p57 K~P2 gene (Hatada et al., 1996) , the Wilms tumor suppressor gene (WT1) (Jinno et al., 1994) , the small nuclear ribonucleoprotein-associated polypeptide N gene (SNRPN) (Oz~elik et al., 1993) , and transcripts (IPW, PAR1 and PAR5) from the Prader-Willi syndrome critical region (Wevrick et al., 1994; Sutcliffe et al., 1994) . Among them, IGF2, SNRPN, IPW, PARI and PAR5 are paternally expressed, and the remaining 3 are maternally expressed genes. Abnormal expression of these genes may have phenotypic effects, e.g., an excess of the active paternal IGF2 allele may lead to an overgrowth syndrome, Wiedemann-Beckwith syndrome (Weksberg et al., 1993) or result in Wilms tumor (Rainier et al., 1993; Ogawa et al., 1993a, b) and lung cancer (Suzuki et al., 1994) .
We previously demonstrated maternal monoallelic-expression of human WT1 in human placental and fetal brain tissues (Jinno et al., 1994) . In contrast to other human imprinted genes, monoallelic expression of WT1 was not universally observed in the villus or brain samples examined. In 4 of 9 villus samples, the gene was expressed biparentally. Thus, our data suggested that WT1 imprinting is tissue-specific and polymorphic in the human population. Alternatively, the WT1 imprinting might be developmental stage-specific and erased in later stages of development, resulting in biparental expression. In order to test these two possibilities, we analyzed WT1 expression in a large number of samples with different gestational ages and in different organs.
MATERIALS AND METHODS
Preparation of genomic DNA, mRNA and its cDNAo A total of 46 placental villus samples aged from 4 to 21 gestational weeks were collected from induced abortuses. Four organs (heart, lung, liver and intestine) were obtained from a 21-week-old fetus. An informed consent was obtained from each pregnant woman, and only the samples from women who had given consent were subjected to this study. All the samples were carefully washed to separate them from maternal blood and decidual tissues, immediately frozen in liquid nitrogen, and then ground to powder. A part of the powdered tissue was treated with proteinase K/SDS and genomic DNA was prepared with phenol/chloroform treatment and ethanol precipitation. RNA was extracted from the powdered tissue using an RNA extraction kit (Nippon Gene, Tokyo) or according to the guanidine thiocyanatephenol/chloroform method. Single-stranded cDNAs were synthesized from 5-10 mg of total RNA using the oligo-dT primer (GIBCO BRL, USA) as described previously (Jinno et aL, 1994) .
Reverse transcriptase-based (RT) PCR and detection of allele-specific expression of WT1. Allele-specific transcription of WT1 was studied on PCR products that were amplified using two sets of primers (Jinno et al., 1994) , i.e., one set (WTCA3 and WTCB3) flanking the polymorphic CA repeat sequences (Gessler et al., 1992) and the other set (WTHfa and WYHfb) for a HinfI restriction fragment length polymorphism (RFLP) (Hoban and Kesley, 1990) , both located in the 3"-untranslated region (UTR) of WT1. The sequences of the two primer sets (5" to 3') are as follows: WTCA3, ATCCATTGTTTAAAGATGGTCG; WTCB3, GTAAATAATAAATTCCCTCCCTT; WTHfa, AATCAGAGAGCAAGGCA-TCG; WTHfb, GTGCAAGGAGGTATGTACATC. The cDNA (2-10ng) and genomic DNA (250 ng) were subjected to PCR with denaturation at 94°C for 1.5 min, annealing at 55°C for 1.5 min and extension at 72°C for t.75 rain, in a 50/21 standard reaction mixture. After 20, 25, 30 and 35 cycles of PCR, the amount of amplified DNA was estimated by electrophoresis on a 4% polyacrylamide gel. A second round of PCR was carried out for 14 cycles in a 10~ul reaction mixture containing WTCA3 and WTCB3 primers, 1/21 each of [a-a2P] dCTP and the first PCR products, with the same PCR conditions. The radiolabeled product (2/zl) was electrophoresed in 6% polyacrylamide/8 M urea sequencing gel. The Hinfl RFLP was detected by Hinfl-digestion of PCR products, followed by electrophoresis in 6% acrylamide gel and staining with ethidium bromide.
RESULTS

Maternal rnonoallelic expression in chorionic villi
Of the 46 RT-PCR products from respective placental villus samples, 18 were informative for the differential expression between the maternal and paternal alleles (Table 1) . Among the 18 informative samples, 7 (39%) showed monoallelic WT1 expression, the expressed .allele being mainly or exclusively maternal, while the remaining I1 samples showed biallelic expression (Figs. I and 2 ).
Monoallelic expression of WTI is not correlated with gestational weeks
Ages of the villus samples with monoallelic or biallelic expressions tended to be diversely distributed at a period of 4-21 gestational weeks (Table 1 ). In this period of development, there was no correlation of monoallelic expression with gestational age, e.g., the villus from a 4-week-old embryo, the youngest sample in our series, showed biallelic expression of WT1, while that from a 21-week-old fetus, the oldest sample, exhibited monoatlelic expression. 
Tissue-specific monoallelic expression of WT1
Analysis of WT1 expression in different organs was possible only in a 21-week-old fetus. All four organs (heart, lung, liver and intestine) from the fetus showed biallelic WT1 expression, although the expression of the villus sample of the same fetus was monoallelic (Fig. 3) . The brain tissue of the fetus was not available.
POLYMORPIqIC AND TISSUE-SPECIFIC IMPRINTING G C V kiLuH I 209 Fig. 3 . Tissue-specific allele expression patterns of WT1. PCR-amplified 3'-UTR CA repeat sequences of genomic DNA (G) and those of eDNA (C) from the villus (V), liver (Li), lung (Lu), heart (H) and intestine (1) of a 21-week-old fetus.
DISCUSSION
The results of our previous study showed that WT1 expression in pre-term placentae was either monoallelic or biallelic (Jinno et al., 1994) . However, we were unable to exclude the possibility that the expression patterns observed would change with increasing fetal age. In other words, WTI would first be expressed from the maternal allele in an early developmental stage and subsequently from both alleles by "loss of imprinting," as observed in the human H19 gene (Jinno et al., 1995) , through a putative gene silencer-mediated mechanism similar to that in the mouse Igf2 (Surani, 1993) . However, the present study provided unequivocal evidence for an imprinting polymorphism of WTI, since the different expression patterns of the gene did not correlate to developmental stages. The human IGF2R is another imprinted gene possibly showing an imprinting polymorphism (Xu et al., 1993) . Although imprinting of IGF2R, whose mouse homologue (Igf2r) was reported to be maternally expressed, had first been denied (Kalscheuer et aL, 1993) , its maternal monoallelic expression was demonstrated in 2 of 14 villus tissues examined (Xu et aL, 1993) .
WT1 contributes to the differentiation of mesenchymal cells or renal vesicles in an early stage of human development. The gene product contains a DNA binding domain consisting of 4 zinc finger motifs (Call et aL, 1990) and binds a recognition element common to the early growth response (EGR) family of zinc finger transcriptional activators (Rauscher, 1993) . In contrast to other EGR transcription factors, WT1 behaves as a transcription repressor in transient transfection assays (Madden et aL, 1991) . IGF2 has EGR/WT1 binding sites in its promotors. By binding to the sites, WT1 functions as a potent repressor of IGF2 in vivo (Drumond et al., 1992) . IGF2R also acts as a regulator for IGF2. The IGF2 gene product, IGF-II, deteriorates by binding to its receptor, the IFG2R product (Xu et al., 1993) . From this point of view, it is of great interest why polymorphic imprinting occurs in these two regulating genes. It is plausible that the imprinting polymorphism in WT1 and IGF2R may relate to the IGF2 regulation and a common regulating system may exist involving the three genes. It remains to be seen whether the expression patterns observed in WT1 and IGF2R are related to each other. Alternatively, these two genes might have lost their imprinting through the evolutionary process in mammals. It seems that the imprinting is still maintained in a part of the human population.
Among the 5 organs examined in this study, only the placental villus showed monoallelic expression of WT1. The result, together with the previous finding of monoallelic expression in the villus and fetal brain tissues (Jinno et al., 1994) , confirmed the tissue-specific expression of the gene, although the number of fetuses and organs examined was small in the present study. It remains to be seen whether the tissue specificity plays a role in the development of these organs. We did not observe any phenotypic differences among a series of the placenta and other tissues, irrespective of WT1 expression patterns. This may imply that a growth factor, IGF-II, is regulated normally in these organs, regardless of biallelic or monoallelic expression or even a hemizygous condition of WT1. Tissue-specific imprinting has been reported in the mouse Igf2 (DeChiara et al., 1991) and the human IGF2 (Kalscheuer et al., 1993) . A concept of a regional imprinting factor has recently been proposed through the analysis of the 1GF2 promotor (Vu and Hoffman, 1994) . IGF2 has at least 4 different promotors, PI, P2, P3 and P4. IGF2 transcripts from P1 are always derived from both parental alleles, whereas those from other promotors are from one parental allele (Vu and Hoffman, 1994) . Thus, it is likely that there exists a similar system which regulates different expression patterns of WT1 and this system may lead to tissue-specific expression of the gene.
